Mer

Home / Bovi-Shield GOLD® 5

Bovi-Shield GOLD® 5

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza3-Respiratory Syncytial Virus Vaccine (Modified-Live Virus)

Bovi-Shield GOLD® 5

USES:
Prevents respiratory disease caused by infectious bovine rhinotracheitis (IBR) virus, viremia caused by bovine viral diarrhea (BVD) virus Types 1 and 2, and aids in preventing respiratory disease caused by BVD Types 1 and 2, parainfluenza3 (PI3) virus and bovine respiratory syncytial virus (BRSV) when administered by the subcutaneous route of administration. When administered intramuscularly, Bovi-Shield GOLD 5 aids in preventing respiratory disease caused by IBR, BVD Types 1 and 2, PI3 and BRSV.

Expand All
  • Key Benefits

    •Prevents BVD Types 1 and 2 viremia when administered subcutaneously.

    •Prevents respiratory disease caused by IBR for at least 279 days when administered subcutaneously.

    •Aids in the prevention of respiratory disease caused by BVD Types 1 and 2 for at least 279 days when administered subcutaneously.

    •Aids in the prevention of respiratory disease caused by BRSV and PI3 when administered either intramuscularly or subcutaneously.

    •Shown to be safe when given to pregnant cows or calves nursing pregnant cows.*

    * Do not use in pregnant cattle (abortions can result) unless they were vaccinated, according to label directions, with any Bovi-Shield GOLD FP or PregGuard GOLD FP vaccine pre-breeding initially and within 12 months thereafter. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above. To help ensure

    safety in pregnant cattle, heifers must receive at least 2 doses of any Bovi-Shield GOLD FP or PregGuard GOLD FP vaccine with the second dose administered approximately 30 days prebreeding.

  • Dosage & Adminstration

    Single 2 mL subcutaneous (SC) or intramuscular (IM) dose. Calves vaccinated before 6 months of age should be revaccinated after 6 months of age.